Literature DB >> 15256028

Involvement of SHV-12 and SHV-2a encoding plasmids in outbreaks of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Tunisian neonatal ward.

Thouraya Ben-Hamouda1, Thierry Foulon, Kamel Ben-Mahrez.   

Abstract

Previous genotypic investigations of extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae recovered in a Tunisian neonatal ward revealed the spread of two epidemic strains and a high number of genetically unrelated isolates. The aim of the present study was to determine the role of the dissemination of self-transferrable plasmids harboring bla genes in the outbreaks experienced by the ward. The 49 previously identified clinical isolates of ESBL-producing K. pneumoniae were examined for relationships between their enzymes and plasmids. Analysis of crude extracts by isoelectric focusing showed four beta-lactamase-activities at pI 8.2, 7.6, 6, and 5.4. Clinical isolates contained large plasmids that could be transferred by conjugation and transformation conferring resistance to expanded-spectrum cephalosporins. DNA amplification and sequencing were performed to confirm the identities of transferred beta-lactamases. Nucleotide sequence analysis of SHV-specific PCR products from six isolates identified two bla(SHV) genes corresponding to SHV derived ESBLs, SHV-12 and SHV-2a. PstI digestion of plasmid DNA from transformants revealed six restriction patterns. The occurrence of the prevalent plasmid pattern in both epidemic strains and unrelated isolates indicated that diffusion and endemic persistence of the bla(SHV-ESBL) genes in the ward were due to concomitant spread of epidemic strains and plasmid dissemination among unrelated strains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256028     DOI: 10.1089/1076629041310118

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  8 in total

1.  A novel extended-spectrum TEM-type beta-lactamase, TEM-138, from Salmonella enterica serovar Infantis.

Authors:  Chedly Chouchani; Renaud Berlemont; Afef Masmoudi; Moreno Galleni; Jean-Marie Frere; Omrane Belhadj; Kamel Ben-Mahrez
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania.

Authors:  Bjørn Blomberg; Roland Jureen; Karim P Manji; Bushir S Tamim; Davis S M Mwakagile; Willy K Urassa; Maulidi Fataki; Viola Msangi; Marit G Tellevik; Samwel Y Maselle; Nina Langeland
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

3.  Extended-spectrum beta-lactamase-producing Klebsiella spp. in a neonatal intensive care unit: risk factors for the infection and the dynamics of the molecular epidemiology.

Authors:  K Kristóf; D Szabó; J W Marsh; V Cser; L Janik; F Rozgonyi; A Nobilis; K Nagy; D L Paterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

4.  Molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Tunisia and characterization of their virulence factors and plasmid addiction systems.

Authors:  Basma Mnif; Hela Harhour; Jihène Jdidi; Faouzia Mahjoubi; Nathalie Genel; Guillaume Arlet; Adnene Hammami
Journal:  BMC Microbiol       Date:  2013-06-25       Impact factor: 3.605

Review 5.  Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses.

Authors:  Tirza C Hendrik; Anne F Voor In 't Holt; Margreet C Vos
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

6.  Characterization of ESBL (SHV-12) producing clinical isolate of Enterobacter aerogenes from a tertiary care hospital in Nigeria.

Authors:  Murat Kasap; Kayode Fashae; Sinem Torol; Fetiye Kolayli; Fatma Budak; Haluk Vahaboglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-01-12       Impact factor: 3.944

7.  High levels of extended-spectrum beta-lactamases in a major teaching hospital in Ghana: the need for regular monitoring and evaluation of antibiotic resistance.

Authors:  Noah Obeng-Nkrumah; Kingsley Twum-Danso; Karen A Krogfelt; Mercy J Newman
Journal:  Am J Trop Med Hyg       Date:  2013-09-16       Impact factor: 2.345

8.  Study of a Natural Mutant SHV-Type β -Lactamase, SHV-104, from Klebsiella pneumoniae.

Authors:  Nahed Ben Achour; Omrane Belhadj; Moreno Galleni; Mohamed Ben Moussa; Paola Sandra Mercuri
Journal:  Int J Microbiol       Date:  2014-05-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.